Enanta Pharmaceuticals, Inc. (ENTA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$13.41
Day's range
$14.03

Enanta Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 02/17/2026 3.73 M $58.76 M   91.57% 12.97%
BLACKROCK, INC. 02/12/2026 3.08 M $48.51 M   67.83% 10.70%
FARALLON CAPITAL MANAGEMENT LLC 02/17/2026 2.77 M $43.72 M   30.63% 9.64%
KRENSAVAGE ASSET MANAGEMENT, LLC 02/18/2026 2.77 M $43.63 M   30.83% 9.62%
VANGUARD GROUP INC 01/29/2026 2.30 M $36.30 M   18.72% 8.01%
DEEP TRACK CAPITAL, LP 02/13/2026 1.96 M $30.86 M   100.00% 6.81%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 885.13 K $13.95 M   2.09% 3.08%
MILLENNIUM MANAGEMENT LLC 02/17/2026 670.43 K $10.57 M   -29.29% 2.33%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 645.79 K $10.19 M   30.94% 2.25%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 642.20 K $10.13 M   33.90% 2.23%
HILLSDALE INVESTMENT MANAGEMENT INC. 02/10/2026 422.30 K $6.66 M   100.00% 1.98%
STATE STREET CORP 02/13/2026 523.72 K $8.26 M   10.96% 1.82%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 438.94 K $6.92 M   46.31% 1.53%
02/13/2026 389.69 K $6.15 M   100.00% 1.36%
MARSHALL WACE, LLP 02/13/2026 385.28 K $6.08 M   39.90% 1.34%
MORGAN STANLEY 02/13/2026 339.92 K $5.36 M   20.27% 1.18%
TWO SIGMA INVESTMENTS, LP 02/17/2026 285.45 K $4.50 M   370.09% 0.99%
INVESCO LTD. 02/19/2026 253.81 K $4.00 M   325.16% 0.88%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 234.84 K $3.70 M   3.52% 0.82%
NORTHERN TRUST CORP 02/17/2026 229.89 K $3.63 M   17.35% 0.80%
GOLDMAN SACHS GROUP INC 03/25/2026 218.82 K $3.45 M   31.47% 0.76%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 218.64 K $3.45 M   31.28% 0.76%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 211.61 K $3.34 M   -21.64% 0.74%
D. E. SHAW & CO., INC. 02/17/2026 167.71 K $2.64 M   -25.71% 0.58%
JPMORGAN CHASE & CO 02/11/2026 112.96 K $1.78 M   -8.77% 0.53%
TWO SIGMA ADVISERS, LP 02/17/2026 143.30 K $2.26 M   14.55% 0.50%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 103.90 K $1.64 M   34.06% 0.36%
STONEPINE CAPITAL MANAGEMENT, LLC 02/13/2026 100.00 K $1.58 M   -67.21% 0.35%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 99.88 K $1.58 M   403.96% 0.35%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 99.40 K $1.57 M   252.48% 0.35%
SEI INVESTMENTS CO 02/13/2026 98.78 K $1.56 M   33.75% 0.34%
CITADEL ADVISORS LLC 02/17/2026 93.16 K $1.47 M   100.00% 0.32%
NUVEEN, LLC 02/12/2026 86.06 K $1.36 M   -47.77% 0.30%
OPALEYE MANAGEMENT INC. 04/13/2026 75.00 K $1.18 M   100.00% 0.26%
BANK OF NEW YORK MELLON CORP 02/10/2026 72.59 K $1.14 M   19.99% 0.25%
PDT PARTNERS, LLC 02/17/2026 69.20 K $1.09 M   -19.56% 0.24%
PANAGORA ASSET MANAGEMENT INC 02/13/2026 66.99 K $1.06 M   100.00% 0.23%
BANK OF AMERICA CORP /DE/ 02/17/2026 65.98 K $1.04 M   120.28% 0.23%
SQUAREPOINT OPS LLC 02/13/2026 65.97 K $1.04 M   100.00% 0.23%
DIADEMA PARTNERS LP 02/17/2026 65.14 K $1.03 M   100.00% 0.23%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 63.22 K $996.96 K   100.00% 0.22%
ASSENAGON ASSET MANAGEMENT S.A. 01/09/2026 45.88 K $723.48 K   -15.45% 0.21%
BARCLAYS PLC 02/13/2026 54.99 K $867.18 K   32.12% 0.19%
CAMPBELL & CO INVESTMENT ADVISER LLC 02/12/2026 54.15 K $853.93 K   187.19% 0.19%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 52.73 K $831.52 K   100.00% 0.18%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 02/17/2026 50.43 K $795.34 K   0.00% 0.18%
MAN GROUP PLC 02/17/2026 43.85 K $691.47 K   9.19% 0.15%
ADAR1 CAPITAL MANAGEMENT, LLC 02/18/2026 41.36 K $652.20 K   100.00% 0.14%
EAM INVESTORS, LLC 02/12/2026 40.95 K $645.81 K   100.00% 0.14%
PRUDENTIAL FINANCIAL INC 02/13/2026 40.02 K $631.04 K   100.00% 0.14%

Enanta Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 211 institutional investors and hedge funds held shares of Enanta Pharmaceuticals Inc. The most heavily invested institutionals were:

Hillsdale Investment Management Inc.: 435,510

DIMENSIONAL FUND ADVISORS LP: 203,252

Invesco Ltd.: 182,002

VANGUARD FIDUCIARY TRUST CO: 175,856

Connor, Clark & Lunn Investment Management Ltd.: 125,759

Russell Investments Group, Ltd.: 72,850

91.79% of Enanta Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 33.08 M shares in the last 24 months. This purchase volume represents approximately $459.49 M in transactions.